(Q34729833)

4 August 2017

1 reference

title

Prostate cancer and selenium (English)

1 reference

4 August 2017

1 reference

Mark A Nelson

1

1 reference

4 August 2017

Mary Reid

series ordinal

2

1 reference

4 August 2017

Anna J Duffield-Lillico

series ordinal

3

1 reference

4 August 2017

James R Marshall

series ordinal

4

1 reference

4 August 2017

language of work or name

1 reference

1 February 2002

1 reference

Urologic Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

29

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

67-70

1 reference

Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Selenium in forage crops and cancer mortality in U.S. counties

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Selenium and cancer prevention. Promising results indicate further trials required

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Chemopreventive agents: selenium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Diet, androgens, oxidative stress and prostate cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Lessons from basic research in selenium and cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Trends in death rates and registration rates for prostate cancer in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Estimation issues in clinical trials and overviews

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Dietary selenium: time to act.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Prostate cancer, Incidence, management and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

An analysis of watchful waiting for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900018-6

7 January 2021

10.1016/S0094-0143(02)00018-6

Identifiers

DOI

1 reference

4 August 2017

1 reference